Total Vaccine Doses Delivered: 367,000 (Weak) (Still No J&J)
Administered: 815,000 (a bit weak) (50,000 J&J - Weak)
People Vaccinated, First Shot: 383,000 - (Very Weak).
Fully Vaccinated: 465,000 (Weak)
% Total Population with at least a First Shot: 53.7 (up 0.1)
Those ≥ 18 Years of Age (Adults): 65.7% (up 0.1)
Those ≥ 65 Years of Age: 87.5 % (up 0.1) (77.4% Fully Vaccinated - up 0.1)
Cases, Hospitalizations and Deaths low, with a flat trend, to slightly down. Kind of a new plateau over the last 2-3 weeks, with a slight downward slope.
354 Deaths (flat trend)
We have now passed 600,000 American deaths from COVID-19.
https://www.msn.com/en-us/health/medical/benefits-of-covid-19-vaccination-clearly-outweigh-risks-of-rare-heart-inflammation-cdc-vaccine-advisers-told/ar-AALmQzC
"During Wednesday's meeting, CDC researchers said the benefits of vaccination were clear. For every million second-dose vaccinations, there may be tens of myocarditis cases, but thousands of Covid-19 cases prevented, the CDC said.
The myocarditis risk is higher for boys than girls. Among adolescent boys ages 12 to 17, CDC researchers estimate that for every 1 million second-dose vaccinations, 5,700 Covid-19 cases, 215 hospitalizations, 71 intensive care unit admissions and two deaths would be prevented. It's estimated there might be 56 to 69 myocarditis cases (but no deaths from them)."
For all older age groups (male of female), the benefits of vaccination increasingly outweigh risks from myocarditis, the older the group.
Worth consideration...
“Monica Gandhi MD, MPH
@MonicaGandhi9
·
21h
Since US & Israel seeing more cases of myocarditis in young with 2nd dose & use 3 weeks spacing - whereas UK uses 8-12 weeks & not seeing the number of cases of myocarditis- increasing that spacing between doses could help. Prior tweets - 1 dose Pfizer 94% effective against delta”
i believe the 3 week spacing was chosen as the earliest possible- to speed up the trials.
Of course I don’t generally approve of vaxxing the young anyway.
https://www.reuters.com/business/healthcare-pharmaceuticals/us-panel-review-heart-inflammation-cases-after-pfizer-moderna-vaccines-2021-06-23/
Johnson & Johnson vaccine effective against variants: study
The Johnson & Johnson COVID-19 vaccine produces several immune responses allowing it to be effective against different variants of the virus, according to a study released Wednesday.
The research, published in Nature as an accelerated article preview, determined that the Johnson & Johnson vaccine activated immune responses against the original COVID-19 strain, as well as the Alpha, Beta, Gamma and Epsilon variants.
The study concluded that the Johnson & Johnson vaccine “offered strong protection against symptomatic” cases of COVID-19 in South Africa and Brazil where variants have caused most sequenced cases.
Researchers studied the antibody and cellular immune responses of 20 volunteers between the ages of 18 and 55.
The study did find that less neutralizing antibodies appeared when fighting against the Beta and Gamma variants, first found in South Africa and Brazil, respectively, when compared to the original COVID-19 strain.
Those with the Beta strain produced five-times fewer neutralizing antibodies than those with the original strain. For the Gamma variant, people developed 3.3 times less of these antibodies.
But the non-neutralizing antibody and T cell immune responses were “largely preserved” and made up for it when combating the variants, which researchers said indicated how these immune responses could protect against COVID-19 and its variants.
The study determined that a single dose of Johnson & Johnson protected against severe COVID-19 in 86 percent of participants in the U.S., 88 percent of those in Brazil and 82 percent in South Africa.
[[[ Not enough information on the new Delta variant, afaik, for any of the vaccines. Presumably they will help but it’s early. ]]]
From California...
“joint sharing is now safe again with... fully vax’d people”
https://twitter.com/MonicaGandhi9/status/1408118730920316929
Never had a thought of how the pandemic affected dopers...